GenMont Biotech Incorporation (TPE:3164)
Taiwan · Delayed Price · Currency is TWD 15.70
-0.05 (-0.32%)
Sep 15, 2026, 1:21 PM CST
TPE:3164 Market Cap
TPE:3164 has a market cap or net worth of 1.35 billion as of September 15, 2026. Its market cap has decreased by -21.02% in one year.
Market Cap
1.35B
Enterprise Value
1.25B
Revenue
382.11M
Ranking
n/a
PE Ratio
19.60
Stock Price
15.70
ChartMarket Cap Chart
Since May 8, 2006, TPE:3164's market cap has increased from 899.18M to 1.35B, an increase of 50.18%. That is a compound annual growth rate of 2.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 1.35B | -14.44% |
| Dec 31, 2025 | 1.58B | -9.68% |
| Dec 31, 2024 | 1.75B | -18.22% |
| Dec 29, 2023 | 2.14B | 4.39% |
| Dec 30, 2022 | 2.05B | -2.67% |
| Dec 30, 2021 | 2.10B | 9.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Andros Pharmaceuticals Co.,Ltd | 1.69B |
| Synbio Tech | 1.55B |
| Greenyn Biotechnology | 1.54B |
| TaiRx | 1.46B |
| Advagene Biopharma | 1.46B |
| U-Neuron Biomedical | 1.40B |
| NeoCore Technology | 1.27B |
| Abnova (Taiwan) | 1.23B |